Avalyn Pharma Inc. Common Stock (AVLN) — Long-term Investment Intensity
Avalyn Pharma Inc. Common Stock (AVLN) has a Long-term Investment Intensity of 6.0% as of December 2024. Long-term investments of $7.49 Million represent 6.0% of total assets of $124.52 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Avalyn Pharma Inc. Common Stock (AVLN) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Avalyn Pharma Inc. Common Stock Long-term Investment Intensity (2024–2024)
This chart shows how Avalyn Pharma Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the intensity stands at 6.0%, reflecting long-term investments of $7.49 Million against total assets of $124.52 Million USD. Also explore Avalyn Pharma Inc. Common Stock (AVLN) total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Avalyn Pharma Inc. Common Stock (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Avalyn Pharma Inc. Common Stock from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Avalyn Pharma Inc. Common Stock.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 6.0% | $7.49 Million | $124.52 Million | — |